ArticleBreast cancer research and treatment2024

Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.

Saki Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.